In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
Atea Pharmaceuticals Inc (NASDAQ: AVIR) closed the day trading at $2.87 up 0.70% from the previous closing price of $2.85. In other words, the price has increased by $0.70 from its previous closing price. On the day, 0.58 million shares were traded. AVIR stock price reached its highest trading level at $2.88 during the session, while it also had its lowest trading level at $2.785.
Ratios:
For a better understanding of AVIR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 24.85 and its Current Ratio is at 24.85. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on August 13, 2024, Upgraded its rating to Equal-Weight and sets its target price to $6.88 from $2 previously.
Morgan Stanley Downgraded its Equal-Weight to Underweight on January 06, 2022, whereas the target price for the stock was revised from $14 to $7.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 10 ’24 when BERGER FRANKLIN M sold 359,606 shares for $2.85 per share. The transaction valued at 1,023,475 led to the insider holds 451,897 shares of the business.
Franklin Berger bought 359,606 shares of AVIR for $1,023,475 on Dec 10 ’24. On Sep 17 ’24, another insider, Sommadossi Jean-Pierre, who serves as the President, CEO, and Chairman of the company, sold 33,941 shares for $4.05 each. As a result, the insider received 137,318 and left with 5,890,053 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVIR now has a Market Capitalization of 245457312 and an Enterprise Value of -207621744.
Stock Price History:
The Beta on a monthly basis for AVIR is 0.18, which has changed by -0.2264151 over the last 52 weeks, in comparison to a change of 0.07545352 over the same period for the S&P500. Over the past 52 weeks, AVIR has reached a high of $4.14, while it has fallen to a 52-week low of $2.60. The 50-Day Moving Average of the stock is -4.16%, while the 200-Day Moving Average is calculated to be -13.52%.
Shares Statistics:
Over the past 3-months, AVIR traded about 336.08K shares per day on average, while over the past 10 days, AVIR traded about 530020 shares per day. A total of 84.46M shares are outstanding, with a floating share count of 67.18M. Insiders hold about 21.44% of the company’s shares, while institutions hold 63.30% stake in the company. Shares short for AVIR as of 1743379200 were 3011739 with a Short Ratio of 8.96, compared to 1740700800 on 2867436. Therefore, it implies a Short% of Shares Outstanding of 3011739 and a Short% of Float of 4.9200002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
